Vestibo Tablet
Betahistine Dihydrochloride
8mg
National Healthcare Pvt. Ltd.
| Pack size | 100'st |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 6.00 NPR |
Available as:
Indications
Vestibo Tablet is used for:
Meniere's disease, tinnitus and/or progressive loss of hearing, vertigo, dizziness.
Adult Dose
Adult: Initially, 8-16 mg tid. Maintenance: 24-48 mg daily.
Child Dose
Renal Dose
Administration
Should be taken with food.
Contra Indications
Phaeochromocytoma. Porphyria.
Precautions
Active peptic ulcer, bronchial asthma, pregnancy and lactation.
Pregnancy-Lactation
Interactions
May antagonise antihistamines. May decrease bronchodilator effects of beta-2 agonists.
Adverse Effects
Side effects of Betahistine Dihydrochloride :
Rash, pruritus, urticaria, dyspepsia, nausea, peptic ulcer disease, headache, dizziness, insomnia.
Mechanism of Action
Betahistine improves the microcirculation in the labyrinth which reduces endolymphatic pressure.
Note
Vestibo 8mg Tablet manufactured by National Healthcare Pvt. Ltd.. Its generic name is Betahistine Dihydrochloride. Vestibo is availble in Nepal.
Farmaco Nepal drug index information on Vestibo Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.